SCHEMBL4880757

SCHEMBL4880757

Cc1c(N)c(-c2ccn(-c3ccccc3)n2)nn1-c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.57
HTT P42858 3/20 0.54
ALDH1A1 P00352 4/20 0.44
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
CYP1A2 P05177 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP2C19 P33261 1/20 0.41
HPGD P15428 2/20 0.39
MAPT P10636 4/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
STAT1 P42224 1/20 0.39
L3MBTL1 Q9Y468 3/20 0.38
KDM4E B2RXH2 2/20 0.38
POLB P06746 1/20 0.38
APEX1 P27695 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6966371 0.73 SMN1; SMN2 (1.00) SMN1; SMN2HTTALDH1A1MEN1KMT2A
Water SCHEMBL11652814 0.72 SMN1; SMN2 (0.96) SMN1; SMN2HTTALDH1A1MEN1KMT2A
SCHEMBL519346 0.70 HTT (1.00) SMN1; SMN2HTTALDH1A1MEN1KMT2A
SCHEMBL13679138 0.69 HTT (0.65) SMN1; SMN2HTTALDH1A1MEN1KMT2A
SCHEMBL218118 0.69 KMT2A (0.57) SMN1; SMN2HTTALDH1A1MEN1KMT2A
SCHEMBL7517044 0.68 SMN1; SMN2 (0.64) SMN1; SMN2HTTALDH1A1MEN1KMT2A
SCHEMBL9122083 0.68 HTT (0.42) SMN1; SMN2HTTALDH1A1MEN1KMT2A
Ammonia Solution, Strong SCHEMBL10418488 0.68 KMT2A (0.55) SMN1; SMN2HTTALDH1A1MEN1KMT2A
SCHEMBL12854024 0.68 HTT (0.50) HTTALDH1A1KMT2AHPGDMAPT
SCHEMBL631878 0.67 CYP2C9 (0.47) SMN1; SMN2HTTCYP1A2MAPK1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080036373-A1 Platinum complex and light-emitting device TAKASAGO INTERNATIONAL CORPORATION 2008-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080036373-A1 Platinum complex and light-emitting device XPA, ERCC4, UACA SMN1; SMN2 3831/4885HTT 2704/4885ALDH1A1 3924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.